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Abstract
In the Netherlands, toxoplasmosis ranks second in disease burden among foodborne patho-
gens with an estimated health loss of 1,900 Disability Adjusted Life Years and a cost-of-ill-
ness estimated at €45 million annually. Therefore, effective and preferably cost-effective
preventive interventions are warranted. Freezing meat intended for raw or undercooked
consumption and improving biosecurity in pig farms are promising interventions to prevent
Toxoplasma gondii infections in humans. Putting these interventions into practice would
expectedly reduce the number of infections; however, the net benefits for society are
unknown. Stakeholders bearing the costs for these interventions will not necessary coincide
with the ones having the benefits. We performed a Social Cost-Benefit Analysis to evaluate
the net value of two potential interventions for the Dutch society. We assessed the costs
and benefits of the two interventions and compared them with the current practice of educa-
tion, especially during pregnancy. A ‘minimum scenario’ and a ‘maximum scenario’ was
assumed, using input parameters with least benefits to society and input parameters with
most benefits to society, respectively. For both interventions, we performed different sce-
nario analyses. The freezing meat intervention was far more effective than the biosecurity
intervention. Despite high freezing costs, freezing two meat products: steak tartare and mut-
ton leg yielded net social benefits in both the minimum and maximum scenario, ranging from
€10.6 million to €31 million for steak tartare and €0.6 million to €1.5 million for mutton leg.
The biosecurity intervention would result in net costs in all scenarios ranging from €1 million
to €2.5 million, due to high intervention costs and limited benefits. From a public health per-
spective (i.e. reducing the burden of toxoplasmosis) and the societal perspective (i.e. a net
benefit for the Dutch society) freezing steak tartare and leg of mutton is to be considered.
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Introduction
The protozoan parasite Toxoplasma gondii (further referred to as T. gondii) is infecting a third
of the human population globally and may cause toxoplasmosis [1]. Acquired toxoplasmosis
in immunocompetent persons in general occurs without clinical symptoms, while in immuno-
compromised individuals uncontrolled multiplication of the parasite can have severe and
potentially fatal implications, such as encephalitis [2]. During pregnancy, the parasite might
be transmitted via the placenta and infect the fetus with varying severity from asymptomatic
infection to life-threatening risk for the fetus and infant [2].
Cats are the definitive hosts of T. gondii: infected cats spread the parasite via oocysts
excreted in their feces infecting warm blooded animals and humans either via direct contact
or indirectly via the environment [3]. In livestock, toxoplasmosis mostly goes unnoticed as
asymptomatic, but especially pregnant sheep and goats may have an abortion [4, 5]. However,
tissue cysts can develop in all organs and tissues, including muscles of meat producing animals.
Consumption of undercooked or raw meat products is therefore an important exposure path-
way for humans. Humans can also become infected by ingestion of cat-shed oocysts via con-
taminated water or food, or via direct contact with cat feces [2, 6]. Additionally, congenital
transmission can occur after primary infection during pregnancy [3, 6].
In the Netherlands, toxoplasmosis ranks second in disease burden among 14 foodborne
diseases with in total 1,900 Disability Adjusted Life Years (DALY) in 2017, and additional
cost-of-illnesses of €45 million [7, 8]. Given the burden of disease associated with T. gondii,
effective and cost-effective preventive interventions are warranted. In the Netherlands, with
an observed seroprevalence of 18.5% in women of reproductive age [9], toxoplasmosis pre-
vention is targeted at education during pregnancy [10], similar to most other western Euro-
pean countries [11]. However, these interventions do not prevent acquisition of infections
in the general population, whereby exposure via food (~56% of all symptomatic T. gondii
infections in the Netherlands) is considered to be the most important route of infection [8].
Opsteegh et al. (2015) suggested—based on a quantitative risk assessment model—that freez-
ing of raw consumed meat products would be effective to reduce the burden of disease as
freezing meat at −20˚C for 2 days eliminates infectious T. gondii tissue cysts [10, 12]. Other
potential intervention measures are improving biosecurity to reduce exposure of the meat-
producing animals to oocysts, and improved education to pregnant women and the general
public [13]. Improved biosecurity on pig farms is considered an important factor in the
decrease of seroprevalence observed in human populations [10]. The European Food Safety
Authority (EFSA) working group has recommended a number of controlled housing condi-
tions to prevent Toxoplasma infection in pigs [14] such as keeping cats away from stables
and feed and implementing strict vermin control. Stringent biosecurity measures might
result in a lower prevalence in pigs, and consequently fewer human infections. For grazing
animals such as cattle or small ruminants, it was assumed to be too difficult to implement
effective biosecurity [10].
Putting new interventions targeted at toxoplasmosis into practice would be expected to
reduce the number of human infections; however, the net benefits for society are unknown. A
Cost-Benefit Analysis, also referred to as a Social Cost-Benefit Analysis (SCBA), expresses
human health, animal health and costs in comparable terms (i.e. monetary units) and is there-
fore the methodology to apply when evaluating the net benefits of a new One Health interven-
tion [15, 16]. An SCBA assesses the costs and benefits for a range of social domains and
stakeholders and identifies those who benefit and parties that have to pay for the intervention.
Here, we describe an SCBA studying two interventions in the food chain to reduce T. gondii
infections in humans in the Netherlands.
Social-cost benefit analysis of preventive interventions for toxoplasmosis
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Methods
Evaluation of intervention measures
The costs and benefits of implementing two interventions were calculated: freezing meat
intended for undercooked and raw consumption, and improving biosecurity on pig farms
(hereafter called freezing meat intervention and biosecurity intervention, respectively). We
assumed that both interventions would be implemented by law, at least at European Union
(EU) level, or globally. Following the assumption of large-scale introduction of interventions,
trade effects were ignored in the current study.
Design of the SCBA
The design of this SCBA has been described in [16]. In short, several types of input data, partly
derived from primary data, partly derived from models, were incorporated in the SCBA, see
Fig 1, and are discussed in more detail hereafter. Not all data were available and assumptions
had to be made. We defined a ‘minimum scenario’ and a ‘maximum scenario’, using input
parameters with least benefits to society and input parameters with most benefits to society,
respectively.
Estimation of incidence, disease burden, cost-of-illness and attribution to
meat
At first, we need T. gondii-related incidence, burden of disease (BoD), and cost-of-illness
(COI) estimates. In Northwestern Europe, including the Netherlands, T. gondii type II pre-
dominates [17, 18] and potential virulence differences between types were not taken into
account. Using an incidence- and pathogen-based approach, [19] BoD and COI for toxoplas-
mosis and associated sequelae were estimated for 2016. Incidence, mortality rates and sequelae
of congenital toxoplasmosis were estimated based on described methods and data [20, 21]
and updated to 2016 using the number of live births as reported by Statistics Netherlands [19–
22]. Chorioretinitis, an inflammation of the choroid and retina in the eye, was the only health
outcome considered for acquired toxoplasmosis [20]. Infections in immunocompromised
patients were not included in the BoD due to data restrictions. Potential associations of toxo-
plasmosis with psychiatric disorders are debated, however solid links between cause and effects
have not been established [23]. Psychiatric disorders because of toxoplasmosis were therefore
not considered in the BoD. The outcome tree for congenital T. gondii infections considers the
health outcomes: chorioretinitis, intracranial calcification, hydrocephalus, central nervous sys-
tem abnormalities, and fetal death [20]. BoD was expressed in Disability Adjusted Life Years
(DALY), a metric combining the Years of Life Lost (YLL) due to premature mortality and the
Years Lost due to Disability (YLD) [24]. The estimation of the BoD is described in detail in the
Supporting Information files (S1 Text).
Healthcare costs, patient costs, special education costs, and productivity losses due to tem-
porary work absences of patients or their caregivers were considered in the COI estimates.
These were based on Mangen et al. (2015) and updated to 2016 prices [7] (S1 Text).
Using an expert elicitation study, human T. gondii cases and associated BoD and COI were
attributed to five major exposure pathways (food, environment, direct animal contact, human-
human transmission and travel) and eleven food groups [25]. Based on these estimates we cal-
culated the meatborne-attributable fraction of BoD and COI for the year 2016 (see S1 and S2
Tables in the Supporting Information files).
Social-cost benefit analysis of preventive interventions for toxoplasmosis
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Fig 1. Design of the SCBA. DALY = Disability Adjusted Life Year, COI = cost-of-illness, DCE = Discrete Choice Experiment, QMRA = Quantitative
Microbial Risk Assessment.
https://doi.org/10.1371/journal.pone.0216615.g001
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Quantitative Microbial Risk Assessment (QMRA)
To estimate the reduction in the number of human toxoplasmosis cases following implementa-
tion of the two interventions as well as associated BoD and COI, we used output data from an
update of the quantitative microbiological risk assessment (QMRA) model for meatborne T.
gondii infections [26] (see S2 Text in the Supporting Information files).
Interventions
Freezing meat intervention. To limit the intervention costs and increase acceptance by
consumers, the freezing meat intervention was considered for meat products with a high rela-
tive contribution: spicy steak tartare (also known as filet ame´ricain, made from beef), beef
steak, lamb chop, and leg of mutton [26]. Information from representatives of the Dutch meat
industry revealed that 50% of all steak tartare is already produced from meat that was frozen
previously. Therefore, for steak tartare, total future freezing costs were calculated for the
remaining 50% and effectiveness estimates were limited to the incremental 50% of meat that
had to be frozen. The numbers of the specific meat products consumed were retrieved from
the Dutch National Food Consumption Survey performed in 2010 [27], see Table 1. Total con-
sumption of all meat products was based on a Dutch report [28]. Additional assumptions are
described in S3 Text in the Supporting Information files.
Biosecurity intervention. Controlled housing at pig farms has the potential to prevent T.
gondii infections of pigs. The biosecurity intervention in this study would entail a practical
risk-based surveillance program on top of the currently established quality assurance and
monitoring at pig farms in the Netherlands. In the case of detection of T. gondii seropositive
pigs during screening at the slaughterhouse, the fattening pig farm would be assumed to con-
duct additional or intensified on-farm intervention measures to control toxoplasmosis. This
would include an additional audit and additional measures to limit exposure to the risk factors
identified (see S3 Text for additional information), resulting in additional costs of €400 (mini-
mum) and €4,000 (maximum)/affected farm (Table 1) and an improved rodent control result-
ing in reduced production costs (Table 1). We assumed that in the minimum scenario in 75%
of the farms with seropositive pigs intensified rodent control is necessary; in the maximum
scenario, this is assumed to be 25%.
Discrete Choice Experiment (DCE)
Freezing and thawing of meat will result in safer meat but might impact the physical quality of
meat (e.g. moisture loss, and changes in color, and pH) [37–40] potentially influencing con-
sumers’ attitudes. Preference of meat consumers for different attributes of frozen meat were
studied in a Discrete Choice Experiment (DCE), (see S4 Text) [41]. As consumers reported
a preference for fresh, non-frozen meat in the DCE, the willingness-to-pay was negative
(Table 2).
Stakeholders
The stakeholders included in this SCBA were consumers (meat consumers, general popula-
tion at risk for toxoplasmosis), producers (farmers, slaughterhouses, freezing companies,
meat processing industry, retailers), and government (including health care and special edu-
cation). Both interventions would affect consumers: fewer human T. gondii infections would
result in better health (fewer DALYs lost), lower patients’ costs and fewer productivity losses.
Due to additional intervention costs, meat prices would rise. The negative WTP estimates
in combination with extra costs due to freezing resulted in a double decline in consumers’
Social-cost benefit analysis of preventive interventions for toxoplasmosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0216615 May 10, 2019 5 / 16
demand for these high-risk meat products. The confidence intervals around the WTP esti-
mates comprised the ‘0’, therefore, no change of WTP was considered in the maximum sce-
nario. As consumers’ preferences in experiments may differ from their behavior in daily life
[42] only 50% of WTP calculations were taken into account in the minimum scenario. The
Table 1. Input parameters for the economic model.
Description Point estimator Unit Min Max Source
BoD and COI attributable to meatborne toxoplasma infections in 2016
DALYs by toxoplasmosis via meatborne infectionsa 326 Estimated�
DALY value 50,000 € [29]
COI of toxoplasmosis via meatborne infectionsa 7.9 million Estimated�
Freezing meat intervention
Pork meat consumptionb 37.4 Kg [28]
Beef meat consumptionb 14.2 Kg [28]
Mutton meat consumptionb 1.2 Kg [28]
Steak tartare portion sizecd g 11 53 [27]
No of portions steak tartarecd 330 million [27]
Meat percentage steak tartare/portiond % 50.84 73.96 QMRA
Steak (beef) portion size g 44 224 [27]
No of steak portionsd 14 million [27]
Lamb chop portion size g 28 214 [27]
No of lamb chop portionsd 3 million [27]
Leg of mutton portion size 158 g [27]
No of leg of mutton portionsd 0.8 million [27]
Price elasticity meat -0.7 [30]
Freezing costs/kg € 0.10 0.15 e
Biosecurity intervention
No of fattening pig farms 4,000 [31]
No fattening pigs/farm 1,450 [31]
No fattening pigs slaughtered/year 15,034,000 [31]
Fattening pigs/lorry when delivered 200 e
No of fattening pigs tested/lorry 1 10 e
Cost serological test 5 € [32]
Positive tested farmsf % 12 20 [33, 34]
Annual costs rodent control/pig farm € 400 4000 g
Feed cost/fattening pig/yearf 65 € [31]
Less spilled feed % 0 0.1 Assumption
Costs for an additional audit (4 hours) 132 € [35]d
Effectiveness 1 % [36]
a discounted at 3% a large part of the associated BoD (in particular the sequelae) and costs do not occur in the year of the infection itself, but happen later in life,
bper person and year in the Netherlands,
csteak tartare also known as filet americain,
dconsumed in the Netherlands per year,
epersonal communication VION Food group,
fassumption based on quadrupling the % of positive tested farms, based on the % of infected pigs in a recent study which is four times higher than found in a previous
study,
gpersonal communication branch organisation of rodent control, averaged 2013–2015,
BoD = Burden of Disease, COI = Cost-of-Illness, DALY = disability adjusted life year,
�We used the average as point estimator, for more details see S1 and S2 Tables.
https://doi.org/10.1371/journal.pone.0216615.t001
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assessment of the consumer surplus (an economic measure of consumer benefit) is explained
in S4 Text.
The interventions will affect the producer surplus, as higher prices of meat will influence
consumers’ demand for meat. As we assume perfect competition among freezing meat compa-
nies and slaughterhouses, the supply curve is horizontal and there is no difference between
market price and supply curve; therefore, we do not take the producer surplus (the benefit
for selling the product, see S4 Text for explications) of the freezing meat intervention into
account [29]. The same applies to the slaughterhouses in the biosecurity intervention. Since
only small changes in the supply of meat throughout the meat chain are expected, we assumed
that changes in supplies of meat had no effect on the profit of any of these stakeholders (i.e.
slaughterhouses, transport companies, freezing industries, food retailers) in the Netherlands.
Additional interventions costs were assumed to be passed through to the consumer, so that
welfare changes for these stakeholders were assumed to be zero. Only in case of the biosecurity
intervention, affected pig farmers will experience a negative welfare effect. The incurred costs
for improving biosecurity cannot be fully compensated by the additional benefits (fewer feed
costs) and cannot be passed on to consumers, since they will involve only a selection of all pig
farmers.
The final stakeholder is the government who, with decreasing number of T. gondii infec-
tions will incur less healthcare costs and less special education costs. However, when farmers
have a lower income due to T. gondii-related investments, and the freezing meat intervention
leads to a lower production of meat, the government will receive less tax revenue. As lower
tax revenues will be compensated by consumers in higher taxes elsewhere, we did not include
these in our study.
Economic evaluation
All available input for the SCBA (see Tables 1 and 2) was synthesized using a Microsoft Excel
model. For the reference scenario, we assumed existing preventive measures by means of
educating pregnant women, to be unchanged and no changes in incidence or prevalence of T.
gondii infections over time. The model estimates the net value by comparing the reference sce-
nario with the two alternative scenarios including reduced T. gondii transmission by calculat-
ing the difference between the costs and benefits in the alternative and the reference scenario.
The net values of costs and benefits are presented per intervention per year, per stakeholder,
using DALY and COI estimates. The monetary value of a DALY was assumed to be €50,000
[29]. All costs were expressed for the year 2016, and we indexed price levels using Dutch con-
sumer price indices as provided by Statistics Netherlands.
Table 2. Attribution to meatborne toxoplasmosis, meat to be frozen, DALYs averted, and WTP for the freezing meat intervention.
Attribution to meatborne toxoplasmosis (%) Meat to be frozen (tons) DALYs averted (N) WTP/kg
Mina Maxb Mina Maxb
Steak tartare 79.82 887.7 6,502.1 208.16 312.25 -€1.64
Beef steak 1.46 6,254.8 32,072.3 3.81 5.71 -€1.13
Lamb chop 0.04 84.7 654.5 0.11 1.16 €0.05
Leg of mutton 3.73 70.8 177.5 9.73 14.60 €0.05
Total 85.05 7298 39406.4 221.81 333.72
a using least economically favorable input parameters,
b using most economically favorable input parameters,
c preferences for leg of mutton were not assessed by DCE, we assumed the same WTP as for lamb chop, WTP = willingness-to-pay
https://doi.org/10.1371/journal.pone.0216615.t002
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Sensitivity and scenario analyses
For both interventions, we performed different scenario analyses. We varied the baseline value
of a DALY from €50,000 (baseline) to € 100,000/DALY for both interventions [29].
For the freezing meat intervention, we calculated results for not assuming perfect competi-
tion between the freezing companies and in this case including the producer surplus in the
model. We varied the meatborne attribution (44% of all toxoplasmosis infections in the
baseline analysis) with a 50% higher and 50% lower estimate and we varied the annual BoD
(expressed as DALYs/year) and COI in the population using the 2.5% and 97.5% (748 DALY/
year and €18.3 million/year in baseline versus 506 DALY/year and €5.1 million/year (2.5%)
and 1063 DALY/year and €53.2 million/year (97.5%), see S1 Table. Lastly, we combined the
50% higher meatborne attribution estimate with a scenario of 1063 DALYs/year and €53.2 mil-
lion/year.
For the biosecurity intervention, we changed the attribution of pig meat products to toxo-
plasmosis as provided by the QMRA with attribution of pig meat products based on expert
elicitations (66% versus 14% in the baseline). In addition, because the effects and the endur-
ance of effects in the biosecurity measure are mostly unknown, we varied effectiveness in addi-
tional sensitivity analyses to 10% effect (versus 1% in baseline), and endurance of 5 and 10
years were used (versus 1 year in baseline), whereby using a 3% discount rate [29].
Results
Freezing meat products
The products steak tartare, lamb chops, leg of mutton, and beef steaks are considered to attri-
bute a risk for meatborne T. gondii infection but no pork products according to the QMRA
and the amount of these meat products to be frozen is shown in Table 2. The relative contribu-
tion of all pork meat is 12%. Depending on the assumptions on portion sizes this varies from
7,298 tonnes up to 39,406.4 tonnes for all four products annually for the Netherlands. QMRA
results show that freezing these meat products would lead to a decline of 85% of all meatborne
T. gondii infections and its corresponding DALYs, ranging from 222 to 334 DALYs averted.
Table 3 presents costs and benefits for freezing the four meat products from Table 2. Using
the least economically favorable input parameters in the model (the ‘minimum scenario’) the
intervention would lead to annual net benefit of €10.6 million and €0.6 million for respectively
steak tartare and leg of mutton, but would not render benefits for the other two products.
Using the most favorable input parameters (the ‘maximum scenario’) freezing steak tartare
and leg of mutton would lead to annual total net benefits of €31 million and €1.5 million
respectively. Freezing the other risk meat products would still lead to net costs for society.
Monetized DALYs contribute most to benefits of the freezing intervention, followed by
avoided healthcare costs (Table 3). Freezing costs are lowest for leg of mutton (€0.008 to
€0.028 million) and highest for beef steak (€0.6 to €4.8 million) in line with the volume con-
sumed in the Netherlands. Freezing beef steak would result in the lowest consumer surplus
(ranging from -€0.6 million to -€2.7 million).
Improving biosecurity on pig farms
Improving biosecurity on pig farms results in costs ranging from €1.1 million in the ‘maxi-
mum scenario’ to €2.5 million in the ‘minimum scenario’ as costs easily outweigh the benefits
of the intervention (Table 4). In both scenarios, farmers have the highest costs by implement-
ing professional rodent control of mice and casts from the stables. In addition, consumers
incur costs as serological costs paid by slaughterhouses would be put through to consumers;
Social-cost benefit analysis of preventive interventions for toxoplasmosis
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leading to higher consumer prices. Most benefits are realized by monetized DALYs, ranging
from 47 to 31 DALYs averted, and from avoided healthcare costs.
Sensitivity analyses
Results of the sensitivity and scenario analyses are presented in Table 5. In all cases, freezing
steak tartare and leg of mutton would still lead to savings to society. Increasing the DALY
value to €100,000 had the highest impact on results making freezing both meat products even
Table 3. Net benefits for the stakeholders involved with the freezing meat interventions in 2016 (€)�1000.
Steak tartare Beef steak Lamb chop Leg of mutton
Stakeholdersa Min Max Min Max min max min max
Freezing companiesb -975 -89 -4,811 -626 -98 -8 -28 -8
+975 +89 +4,811 +626 +98 +8 +28 +8
Consumers
Freezing costs -975 -89 -4,811 -626 -98 -8 -28 -8
DALYs averted 10,408 15,612 190 286 5.3 8 487 730
Patient costs 12 24 0.2 0.4 0.0 0.0 0.6 1.1
Productivity losses 199 362 3.6 6.6 0.1 0.2 9 17
Consumer surplus -907 -112 -2,722 -622 -10 -8 -4 -3
Government
Healthcare costs 1,836 15,136 33.6 277 0.9 7.8 86 708
Special education costs 3.2 143.3 0.06 2.6 0.0 0.1 0.2 6.7
Net benefitsc 10,576 31,077 -7305 -625 -102 -0.6 550 1,452
Min: using input parameters that result in economically least favorable outcomes, Max: using input parameters that result in economically most favorable outcomes,
a we assumed no change in costs for farmers and retailers
b Intervention costs occurring in freezing companies will be put through to consumer (so at slaughterhouse level it will be zero),
c note: a negative number corresponds with costs, a positive number with savings
https://doi.org/10.1371/journal.pone.0216615.t003








Intervention costs slaughterhouses -439 -482
DALYs averted 16 23
Patient costs 0.0 0.0
Productivity losses 0.3 0.5
Government
Healthcare costs 3 23
Special education costs 0.0 0.2
Net benefitsb -2,525 -1,136
Min: using least economically favorable input parameters, Max: using most economically favorable input parameters,
aIntervention costs occurring in slaughterhouses will be put through to consumer (so at slaughterhouse level it will be
zero),
b note: a negative number corresponds with costs, a positive number with savings
https://doi.org/10.1371/journal.pone.0216615.t004
Social-cost benefit analysis of preventive interventions for toxoplasmosis
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Table 5. Results sensitivity and scenario analysis, net benefits in €1000.
Freezing meet intervention
Min Relative change compared to main
analysis %
Max Relative change compared to main
analysis %
Main analysis
Steak tartare 10,576 31,077
Beef steak -7,305 -676
Lamb chop -102 -0.6
Leg of mutton 551 1,452
DALY valuation €100,000
Steak tartare 20,984 98 46,689 50
Beef steak -7,114 -3 -390 -42
Lamb chop -96 -5 7 -1360
Leg of mutton 1,037 88 2,182 50
No perfect competition between freezing companies
Steak tartare 10,495 -1 31,055 0
Beef steak -7,526 3 -800 18
Lamb chop -104 2 -2.6 339
Leg of mutton 550 0 1,451 0
Meatborne attribution 50% lower (22% versus 44% in baseline)
Steak tartare 9,551 -10 23,244 -25
Beef steak -7,323 0 -819 21
Lamb chop - 102 1 -5 683
Leg of mutton 503 -9 1,086 -25
Meatborne attribution 50% higher (66% versus 44% in baseline)
Steak tartare 11,601 10 38,910 25
Beef steak -7,286 0 -532 -21
Lamb chop -101 -1 3 -683
Leg of mutton 598 9 1,818 25
Lower estimate (2.5%) for BoD and COI in the population
Steak tartare 6,525 -38 20,907 -33
Beef steak -7,379 1 -862 28
Lamb chop -104 2 -6 886
Leg of mutton 361 -34 976 -33
Higher estimate (97.5%) for BoD and COI in the population
Steak tartare 15,773 49 44,125 42
Beef steak -7,210 -1 -437 -35
Lamb chop -99 -3 6 -1137
Leg of mutton 794 44 2.,062 42
Meatborne attribution 50% higher & higher estimate (97.5%) for BoD and COI in the population
Steak tartare 17,225 63 55,226 78
Beef steak -7,183 -2 -234 -65
Lamb chop - 98 -3 12 -2104
Leg of mutton 861 56 2,581 1725
Biosecurity interventiona
Main analysis -2,525 -1,136
DALY valuation €100,000 -2,509 -1 -1,113 -2
Effectiveness 10% -2,362 -7 -716 -37
(Continued)
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more favorable. Increasing the meatborne attribution estimate with 50% in combination
with a higher annual burden (expressed as higher number of DALYs/year and COI/year) also
resulted in more net benefits to society. If no perfect competition between freezing companies
was assumed, this had hardly any effect on the results.
A higher DALY value and increasing the effectiveness of the biosecurity intervention to
10% instead of 1% would not result in net benefits for society. In addition, when an attribution
of pig meat products to toxoplasmosis was based on expert elicitations (66%) instead of the pig
meat attribution from the QMRA of 12%, it did not result in net benefits for society (Table 5).
Results for higher effectivity implying a fivefold (5%) or a tenfold (10%) reduction of the dis-
ease burden of toxoplasmosis associated with the biosecurity intervention lasting to pork for
five or ten years are presented in S1–S6 Figs.
Discussion
In this SCBA we compared the costs and benefits of adding two interventions targeted at
reducing the T. gondii-related BoD to current practice which is focused solely on educating
pregnant women and other risk groups. The intervention related to freezing high-risk meat
(products) is far more effective in reducing BoD than the intervention to improve the biosecu-
rity on pig farms. Freezing steak tartare and mutton leg yield annual net social benefits in both
the minimum and maximum scenario, ranging from €11 million to €31 million for steak tar-
tare and €0.6 to €1.5 million for leg of mutton. These results remained robust in sensitivity
analysis. The estimated risk of infection per portion of steak tartare is low (4.5 × 10−4) but
this product is eaten frequently in the Netherlands. Leg of mutton is eaten infrequently in the
Netherlands, but in this case the risk of infection per portion is high (1.1 × 10−2) due to the
high prevalence and bradyzoite concentration in sheep and the heating distribution that allows
for the possibility of undercooking.
The DCE performed in this study revealed that consumers do not prefer to buy industrially
frozen (and thawed) meat [41]. Additional information for consumers seems necessary to con-
vince them to buy ‘toxoplasma-safe’ meat. On the other hand, half of the meat intended for
producing steak tartare and similar meat products is currently frozen, and consumers do not
seem to have knowledge on this fact nor notice a difference between the two variants of the
product. The intervention related to improve biosecurity on pig farms would result in net
costs in all scenarios ranging from €1 to €2.5 annually. These results are driven by high costs
for farmers and consumers and by an assumed 1% effectivity of the intervention with DALYs
averted and associated benefits being low. This could be influenced by the already high level
of biosecurity on pig farms in the Netherlands since the larger part of pig production is under
controlled housing conditions [43].
Although vaccination of the cat population was identified as being a potentially effective
intervention to prevent humans to get infected with oocysts [16], there is yet no vaccine
Table 5. (Continued)
Freezing meet intervention
Min Relative change compared to main
analysis %
Max Relative change compared to main
analysis %
Attribution of pig meat products based on expert
elicitations
-2,469 -2 -1,010 -11
a additional sensitivity analyses are presented in figures in the Supporting Information files,
BoD = Burden of Disease, COI = Cost-of-illness
https://doi.org/10.1371/journal.pone.0216615.t005
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available and the feasibility of implementing such an intervention is questionable (See S5 Text,
Bonacic Marinovic et al. submitted), therefore cat vaccination was not further studied in the
current SCBA.
This SCBA reveals several strengths and limitations. As far as we know, only Van Asseldonk
et al evaluated the costs and benefits of an intervention for toxoplasmosis by improving biose-
curity at pig farms, considering relevant stakeholders [44].
Strengths of the current study are the incorporation of updated information of attributing
risk meat products for acquiring toxoplasmosis and the assessment of consumers’ preferences
towards frozen meat. The main limitations of the study are the uncertainty of incidence of T. gon-
dii infections, for both congenital as acquired infections, and the corresponding BoD and COI,
the uncertainty of the attribution to the main pathways of toxoplasmosis by expert elicitation and
to the meat products by QMRA, and the lack of effectiveness data applied to the biosecurity inter-
vention. Currently, we assumed effectiveness of 1%. If the effectiveness turns out to be more
than 1%, that would lead to a higher net value for the biosecurity intervention in this SCBA. The
intervention, therefore, might be more favorable than we can conclude from our best estimates,
although the scenario analysis indicates that increasing biosecurity would still result in net costs
at 10% effectivity. By freezing and thawing meat, additional steps are introduced in the meat
chain, with a risk of introducing additional hazards with a negative impact on human health. On
the other hand, freezing may also negatively impact the viability of other foodborne pathogens
such as Campylobacter [45]. These possibilities were not considered in the current study.
A main assumption was that the interventions would be imposed by law in the European
Union (at the least), and that trade/market distortion could be ignored. However, if this
assumption does not hold, our results are no longer valid. In the Netherlands around 75% of
all meat is exported, mostly to EU countries [46].
Regarding congenital infections, we only included productivity losses for caregivers, not for
children born with these complications, based on a French study [47]. In France, contrary to
the Netherlands, screening during pregnancy is implemented, with possibly a different popula-
tion of congenital T. gondii cases. Furthermore, DALY estimations were based on fetal losses
from only 24th week of gestation and onwards. Finally, productivity losses for fetal and neona-
tal deaths were excluded from our calculation based on Dutch SCBA guidance [29]. This dif-
fers from other cost-benefit analyses (e.g. [48]) and other SCBA guidelines.
Price elasticity of meat was not specifically targeted at the separate meat products, and con-
sumers shifting to consuming other meat products with a different predicted probability of
causing T. gondii infection [49, 50] were disregarded.
To evaluate the full economic impact of interventions to control a zoonosis, the influence
on the human and animal health sector need to be integrated for decision makers in all sectors
[15, 51]. We performed an SCBA to assess interventions targeted at the prevention of toxoplas-
mosis and gained insight in a range of mechanisms that influenced total net monetary results.
Using conservative input parameters for the biosecurity intervention in the SCBA model, the
intervention would result in high net costs for farmers and consumers, with only limited posi-
tive effects for consumers. On the contrary, freezing high risk meat products would result in
net benefits for society. More specifically, freezing all steak tartare instead of the current 50%
and leg of mutton are expected to be efficient options to reduce the burden of toxoplasmosis
and increase food safety.
Supporting information
S1 Table. Attribution of toxoplasmosis to main pathways.
(DOCX)
Social-cost benefit analysis of preventive interventions for toxoplasmosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0216615 May 10, 2019 12 / 16
S2 Table. Annual average costs for patients, healthcare, special education, and productivity
losses due to T. gondii infection in the Netherlands, 2016.
(DOCX)
S1 Text. Incidences, Burden of disease (BoD) and cost-of-illness (COI).
(DOCX)
S2 Text. Quantitative Microbial Risk Assessment (QMRA).
(DOCX)




S5 Text. Cat vaccination.
(DOCX)
S1 Fig. Assuming effectiveness 1%, lasting for 5 years in the minimum scenario.
(PDF)
S2 Fig. Assuming effectiveness 1%, lasting for 5 years in the maximum scenario.
(PDF)
S3 Fig. Assuming effectiveness 1%, lasting for 10 years in the minimum scenario.
(PDF)
S4 Fig. Assuming effectiveness 1%, lasting for 10 years in the maximum scenario.
(PDF)
S5 Fig. Assuming effectiveness 10%, lasting for 10 years in the minimum scenario.
(PDF)
S6 Fig. Assuming effectiveness 10%, lasting for 10 years in the maximum scenario.
(PDF)
Author Contributions
Conceptualization: Anita W. M. Suijkerbuijk, Eelco A. B. Over, Marieke Opsteegh, Mattijs
Lambooij, Joke W. B. van der Giessen, G. Ardine de Wit.
Data curation: Anita W. M. Suijkerbuijk, Huifang Deng, Mattijs Lambooij.
Formal analysis: Anita W. M. Suijkerbuijk, Eelco A. B. Over.
Methodology: Eelco A. B. Over.
Supervision: Marie-Josee J. Mangen.
Validation: Eelco A. B. Over, Marie-Josee J. Mangen.
Visualization: Anita W. M. Suijkerbuijk.
Writing – original draft: Anita W. M. Suijkerbuijk.
Writing – review & editing: Eelco A. B. Over, Marieke Opsteegh, Huifang Deng, Paul F. van
Gils, Axel A. Bonačić Marinović, Mattijs Lambooij, Johan J. Polder, Talitha L. Feenstra,
Joke W. B. van der Giessen, G. Ardine de Wit, Marie-Josee J. Mangen.
Social-cost benefit analysis of preventive interventions for toxoplasmosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0216615 May 10, 2019 13 / 16
References
1. Saadatnia G, Golkar M. A review on human toxoplasmosis. Scandinavian journal of infectious diseases.
2012; 44(11):805–14. Epub 2012/07/27. https://doi.org/10.3109/00365548.2012.693197 PMID:
22831461.
2. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet (London, England). 2004; 363(9425):1965–76.
Epub 2004/06/15. https://doi.org/10.1016/s0140-6736(04)16412-x PMID: 15194258.
3. EFSA_BIOHAZ_panel. Public health risks associated with food-borne parasites. EFSA journal. 2018;
16(12).
4. Shaapan RM. The common zoonotic protozoal diseases causing abortion. Journal of parasitic dis-
eases: official organ of the Indian Society for Parasitology. 2016; 40(4):1116–29. Epub 2016/11/24.
https://doi.org/10.1007/s12639-015-0661-5 PMID: 27876900.
5. Dubey JP. Toxoplasmosis of Animals and Humans, second edition. Beltsville, Maryland, U.S.A.: CRC
press; 2010.
6. Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al. Sources of toxoplasma
infection in pregnant women: European multicentre case-control study. European Research Network
on Congenital Toxoplasmosis. BMJ (Clinical research ed). 2000; 321(7254):142–7. Epub 2000/07/14.
https://doi.org/10.1136/bmj.321.7254.142 PMID: 10894691.
7. Mangen MJ, Bouwknegt M, Friesema IH, Haagsma JA, Kortbeek LM, Tariq L, et al. Cost-of-illness and
disease burden of food-related pathogens in the Netherlands, 2011. International journal of food micro-
biology. 2015; 196:84–93. Epub 2014/12/22. https://doi.org/10.1016/j.ijfoodmicro.2014.11.022 PMID:
25528537.
8. Mangen MJ, Friesema IH, Pijnacker R, Mughini Gras L, Van Pelt W. Disease burden of food-related
pathogens in the Netherlands, 2017 Bilthoven2018. https://www.rivm.nl/bibliotheek/rapporten/2018-
0037.pdf.
9. Hofhuis A, van Pelt W, van Duynhoven YT, Nijhuis CD, Mollema L, van der Klis FR, et al. Decreased
prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands
between 1995/1996 and 2006/2007. Epidemiology and infection. 2011; 139(4):530–8. Epub 2010/05/
25. https://doi.org/10.1017/S0950268810001044 PMID: 20492743.
10. Opsteegh M, Kortbeek TM, Havelaar AH, van der Giessen JW. Intervention strategies to reduce human
Toxoplasma gondii disease burden. Clinical infectious diseases: an official publication of the Infectious
Diseases Society of America. 2015; 60(1):101–7. Epub 2014/09/17. https://doi.org/10.1093/cid/ciu721
PMID: 25225234.
11. Rorman E, Zamir CS, Rilkis I, Ben-David H. Congenital toxoplasmosis—prenatal aspects of Toxo-
plasma gondii infection. Reproductive toxicology (Elmsford, NY). 2006; 21(4):458–72. Epub 2005/11/
29. https://doi.org/10.1016/j.reprotox.2005.10.006 PMID: 16311017.
12. Kotula AW, Dubey JP, Sharar AK, Andrews CD, Shen SK, Lindsay DS. Effect of freezing on infectivity
of of Toxoplasma gondii tissue cysts in pork. Journal of Food Protection. 1991; 54(9):687–90.
13. Di Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D’Amico R, et al. Prenatal education for congenital
toxoplasmosis. The Cochrane database of systematic reviews. 2015;(10):Cd006171. Epub 2015/10/
24. https://doi.org/10.1002/14651858.CD006171.pub4 PMID: 26493047.
14. EFSA. Technical specifications on harmonised epidemiological indicators for public health hazards to
be covered by meat inspection of swine. EFSA J. 2011; 9(10):2371.
15. Belli P, Anderson J, Barnum H, Dixon J, Tan JP. Economic Analysis of Investment Operations—Analyti-
cal Tools and Practical Applications. Washington DC: The World Bank; 2001.
16. Suijkerbuijk AWM, van Gils PF, Bonacic Marinovic AA, Feenstra TL, Kortbeek LM, Mangen MJ, et al.
The design of a Social Cost-Benefit Analysis of preventive interventions for toxoplasmosis: An example
of the One Health approach. Zoonoses and public health. 2017. Epub 2017/11/14. https://doi.org/10.
1111/zph.12417 PMID: 29131528.
17. Ajzenberg D, Cogne N, Paris L, Bessieres MH, Thulliez P, Filisetti D, et al. Genotype of 86 Toxoplasma
gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings.
The Journal of infectious diseases. 2002; 186(5):684–9. Epub 2002/08/27. https://doi.org/10.1086/
342663 PMID: 12195356.
18. Shwab EK, Zhu XQ, Majumdar D, Pena HF, Gennari SM, Dubey JP, et al. Geographical patterns of
Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping. Parasitology. 2014;
141(4):453–61. Epub 2014/01/31. https://doi.org/10.1017/S0031182013001844 PMID: 24477076.
19. Mangen MJ, Plass D, Havelaar AH, Gibbons CL, Cassini A, Muhlberger N, et al. The pathogen- and
incidence-based DALY approach: an appropriate [corrected] methodology for estimating the burden of
infectious diseases. PloS one. 2013; 8(11):e79740. Epub 2013/11/28. https://doi.org/10.1371/journal.
pone.0079740 PMID: 24278167.
Social-cost benefit analysis of preventive interventions for toxoplasmosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0216615 May 10, 2019 14 / 16
20. Havelaar AH, Kemmeren JM, Kortbeek LM. Disease burden of congenital toxoplasmosis. Clinical infec-
tious diseases: an official publication of the Infectious Diseases Society of America. 2007; 44(11):1467–
74. Epub 2007/05/08. https://doi.org/10.1086/517511 PMID: 17479945.
21. Kortbeek LM, Hofhuis A, Nijhuis CD, Havelaar AH. Congenital toxoplasmosis and DALYs in the Nether-
lands. Memorias do Instituto Oswaldo Cruz. 2009; 104(2):370–3. Epub 2009/05/12. PMID: 19430666.
22. Statline [March 14 2017]. http://statline.cbs.nl/Statweb.
23. Tyebji S, Seizova S, Hannan AJ, Tonkin CJ. Toxoplasmosis: A pathway to neuropsychiatric disorders.
Neuroscience and biobehavioral reviews. 2019; 96:72–92. Epub 2018/11/27. https://doi.org/10.1016/j.
neubiorev.2018.11.012 PMID: 30476506.
24. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bulle-
tin of the World Health Organization. 1994; 72(3):429–45. Epub 1994/01/01. PMID: 8062401.
25. Havelaar AH, Galindo AV, Kurowicka D, Cooke RM. Attribution of foodborne pathogens using struc-
tured expert elicitation. Foodborne pathogens and disease. 2008; 5(5):649–59. Epub 2008/08/09.
https://doi.org/10.1089/fpd.2008.0115 PMID: 18687052.
26. Opsteegh M, Prickaerts S, Frankena K, Evers EG. A quantitative microbial risk assessment for meat-
borne Toxoplasma gondii infection in The Netherlands. International journal of food microbiology. 2011;
150(2–3):103–14. Epub 2011/08/26. https://doi.org/10.1016/j.ijfoodmicro.2011.07.022 PMID: 21864927.
27. van Rossum CTM, Fransen HR, Verkaik-Kloosterman J, Buurma-Rethans EJM, Ocke´ MC. Dutch
National Food Consumption Survey 2007–2010 Bilthoven: RIVM; 2011 [2019-3-01]. https://www.rivm.
nl/bibliotheek/rapporten/350050006.pdf.
28. Verhoog D, Wijsman H, Terluin I. Vleesconsumptie per hoofd van de bevolking in Nederland, 2005–
2014. Wageningen: LEI Wageningen UR, 2015.
29. Koopmans C, Heyma A, Hof B, Imandt M, Kok L, Pomp M. Werkwijzer voor kosten-batenanalyse in het
sociale domein. Amsterdam: SEO Economisch Onderzoek, 2016.
30. Bunte F. Quick scan CLM-onderzoek. Den Haag: LEI, 2003.
31. Agrimatie. Informatie over de agrosector. www.agrimatie.nl.
32. van Wagenberg CP, Backus GB, Wisselink HJ, van der Vorst JG, Urlings BA. Impact of test sensitivity
and specificity on pig producer incentives to control Mycobacterium avium infections in finishing pigs.
Preventive veterinary medicine. 2013; 111(3–4):286–96. Epub 2013/06/20. https://doi.org/10.1016/j.
prevetmed.2013.05.009 PMID: 23777649.
33. van der Giessen J, Fonville M, Bouwknegt M, Langelaar M, Vollema A. Seroprevalence of Trichinella
spiralis and Toxoplasma gondii in pigs from different housing systems in The Netherlands. Veterinary
parasitology. 2007; 148(3–4):371–4. Epub 2007/07/25. https://doi.org/10.1016/j.vetpar.2007.06.009
PMID: 17646053.
34. Swanenburg M, Boender GJ, Heres L, Koeijer A, Wisselink HJ. Toxoplasma prevalence in Dutch
slaughter pigs in the period 2012–2014. In: Vieria Pinto, editor. Epidemiology and control of hazards in
pork production chain—SAFEPORK One health approach under a concept of farm to fork. Porto, Por-
tugal 2015. p. 69–72.
35. ZIN. Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische
evaluaties in de gezondheidszorg. Amsterdam: Zorginstituut Nederland (ZIN), 2015.
36. Mangen MJ, Havelaar AH, Poppe KP, de Wit GA. Cost-utility analysis to control Campylobacter on
chicken meat: dealing with data limitations. Risk analysis: an official publication of the Society for Risk
Analysis. 2007; 27(4):815–30. Epub 2007/10/26. https://doi.org/10.1111/j.1539-6924.2007.00925.x
PMID: 17958494.
37. Coombs CE, Holman BW, Friend MA, Hopkins DL. Long-term red meat preservation using chilled and
frozen storage combinations: A review. Meat science. 2017; 125:84–94. Epub 2016/12/06. https://doi.
org/10.1016/j.meatsci.2016.11.025 PMID: 27918929.
38. Leygonie C, Britz TJ, Hoffman LC. Impact of freezing and thawing on the quality of meat: review. Meat
science. 2012; 91(2):93–8. Epub 2012/02/14. https://doi.org/10.1016/j.meatsci.2012.01.013 PMID:
22326063.
39. Lagerstedt A, Enfalt L, Johansson L, Lundstrom K. Effect of freezing on sensory quality, shear force
and water loss in beef M. longissimus dorsi. Meat science. 2008; 80(2):457–61. Epub 2008/10/01.
https://doi.org/10.1016/j.meatsci.2008.01.009 PMID: 22063353.
40. Utrera M, Parra V, Estevez M. Protein oxidation during frozen storage and subsequent processing of
different beef muscles. Meat science. 2014; 96(2 Pt A):812–20. Epub 2013/11/10. https://doi.org/10.
1016/j.meatsci.2013.09.006 PMID: 24200575.
41. Lambooij MS, Veldwijk J, van Gils P, Mangen MJ, Over E, Suijkerbuijk A, et al. Consumers’ preferences
for freezing of meat to prevent toxoplasmosis- A stated preference approach. Meat science. 2018;
149:1–8. Epub 2018/11/19. https://doi.org/10.1016/j.meatsci.2018.11.001 PMID: 30448472.
Social-cost benefit analysis of preventive interventions for toxoplasmosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0216615 May 10, 2019 15 / 16
42. Verbeke W, Perez-Cueto FJ, Barcellos MD, Krystallis A, Grunert KG. European citizen and consumer
attitudes and preferences regarding beef and pork. Meat science. 2010; 84(2):284–92. Epub 2010/04/
09. https://doi.org/10.1016/j.meatsci.2009.05.001 PMID: 20374787.
43. Nederlandse_Vakbond_Varkenshouders. Factsheet varkenshouderij, Feiten en cijfers over de Neder-
landse varkenshouderij. 2017.
44. van Asseldonk M, van Wagenberg CP, Wisselink HJ. Break-even analysis of costs for controlling Toxo-
plasma gondii infections in slaughter pigs via a serological surveillance program in the Netherlands.
Preventive veterinary medicine. 2017; 138:139–46. Epub 2017/02/27. https://doi.org/10.1016/j.
prevetmed.2017.01.016 PMID: 28237229.
45. Umaraw P, Prajapati A, Verma AK, Pathak V, Singh VP. Control of campylobacter in poultry industry
from farm to poultry processing unit: A review. Critical reviews in food science and nutrition. 2017; 57
(4):659–65. Epub 2015/04/22. https://doi.org/10.1080/10408398.2014.935847 PMID: 25898290.
46. CBS. Importation and exportation of meat products 2018 [2018 Feb 2]. https://opendata.cbs.nl/statline/
#/CBS/nl/dataset/7137shih/table?ts=1517569457506.
47. Berrebi A, Assouline C, Bessieres MH, Lathiere M, Cassaing S, Minville V, et al. Long-term outcome of
children with congenital toxoplasmosis. American journal of obstetrics and gynecology. 2010; 203
(6):552.e1-6. Epub 2010/07/17. https://doi.org/10.1016/j.ajog.2010.06.002 PMID: 20633868.
48. Prusa AR, Kasper DC, Sawers L, Walter E, Hayde M, Stillwaggon E. Congenital toxoplasmosis in Aus-
tria: Prenatal screening for prevention is cost-saving. PLoS neglected tropical diseases. 2017; 11(7):
e0005648. Epub 2017/07/12. https://doi.org/10.1371/journal.pntd.0005648 PMID: 28692640.
49. Mangen MJJ, Burrell AM. Decomposing Preference Shifts for Meat and Fish in the Netherlands. Journal
of Agricultural Economics. 2001; 52(2):16–28.
50. Verbeke W, Ward RW. A fresh meat almost ideal demand system incorporating negative TV press and
advertising impact. Agricultural economics. 25(2–3):359–74.
51. Shaw APM, Rushton J, Roth F, Torgerson PR. DALYs, dollars and dogs: how best to analyse the eco-
nomics of controlling zoonoses. Revue scientifique et technique (International Office of Epizootics).
2017; 36(1):147–61. Epub 2017/09/20. https://doi.org/10.20506/rst.36.1.2618 PMID: 28926019.
Social-cost benefit analysis of preventive interventions for toxoplasmosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0216615 May 10, 2019 16 / 16
